Shares of Tandem Diabetes Care, Inc. (NASDAQ:TNDM – Get Free Report) have earned an average recommendation of “Moderate Buy” from the eighteen research firms that are presently covering the stock, ...

Tandem Diabetes Care (NASDAQ:TNDM – Free Report) had its target price boosted by Barclays from $58.00 to $60.00 in a research ...

Tandem Diabetes Care, Inc. TNDM posted a third-quarter 2024 loss of 36 cents per share compared with the year-ago quarter’s ...

胰岛素输送和糖尿病技术领先企业Tandem Diabetes Care, Inc. (TNDM)在2024年第三季度财报电话会议上报告了公司历史上最高的季度销售额。总裁兼首席执行官John ...

On Monday, Tandem Diabetes Care Inc (TNDM) stock saw a modest uptick, ending the day at $31.37 which represents a slight increase of $0.77 or 2.52% from the prior close of $30.6. The stock opened at ...

Tandem Diabetes Care shares ticked up after hours today on third-quarter results that topped the consensus forecast.

周二，Bernstein SocGen Group对医疗设备公司Tandem Diabetes Care (NASDAQ:TNDM)给出了乐观展望，该公司启动了对该股票的覆盖。分析师给予"跑赢大市"评级，目标价为42.00美元，较该股当前水平有25%的上涨潜力。 这一认可紧随Tandem在胰岛素泵市场的创新步伐。据分析师称，Tandem Diabetes Care正在抓住胰岛素泵需求增长的机遇，这 ...

Tandem Diabetes Care, Inc. TNDM posted a third-quarter 2024 loss of 36 cents per share compared with the year-ago quarter’s reported loss of 38 cents. The figure beat the Zacks Consensus ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...